Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0AE9M
|
||||
Former ID |
DNC012016
|
||||
Drug Name |
Butyl-indol-1-yl-pyridin-4-yl-amine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [534087] | ||
Structure |
Download2D MOL |
||||
Formula |
C17H19N3
|
||||
Canonical SMILES |
CCCCN(C1=CC=NC=C1)N2C=CC3=CC=CC=C32
|
||||
InChI |
1S/C17H19N3/c1-2-3-13-19(16-8-11-18-12-9-16)20-14-10-15-6-4-5-7-17(15)20/h4-12,14H,2-3,13H2,1H3
|
||||
InChIKey |
OSRPQIAWURAKDF-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Alpha-2C adrenergic receptor | Target Info | Inhibitor | [534087] | |
Alpha-2B adrenergic receptor | Target Info | Inhibitor | [534087] | ||
Alpha-2A adrenergic receptor | Target Info | Inhibitor | [534087] | ||
Reactome | Adrenoceptors | ||||
Adrenaline signalling through Alpha-2 adrenergic receptor | |||||
Adrenaline,noradrenaline inhibits insulin secretion | |||||
G alpha (i) signalling events | |||||
G alpha (z) signalling events | |||||
Surfactant metabolismR-HSA-390696:Adrenoceptors | |||||
G alpha (z) signalling eventsR-HSA-390696:Adrenoceptors | |||||
Surfactant metabolism | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.